Diagnosticos da America's Total Liabilities for the quarter that ended in Mar. 2026 was R$10,918 Mil.
Diagnosticos da America's quarterly Total Liabilities
declined
from Sep. 2025 (R$13,257.09 Mil) to Dec. 2025 (R$11,669.23 Mil) and
declined
from Dec. 2025 (R$11,669.23 Mil) to Mar. 2026 (R$10,918.29 Mil).
Diagnosticos da America's annual Total Liabilities
declined
from Dec. 2023 (R$18,879.38 Mil) to Dec. 2024 (R$18,522.82 Mil) and
declined
from Dec. 2024 (R$18,522.82 Mil) to Dec. 2025 (R$11,669.23 Mil).
Diagnosticos da America Total Liabilities Related Terms
Diagnosticos da America Total Liabilities Historical Data
* Premium members only.
The historical data trend for Diagnosticos da America's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnosticos da America Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Diagnosticos da America's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of R$10,918 Mil mean?
Diagnosticos da America (BSP:DASA3) has a Total Liabilities of R$10,918 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Diagnosticos da America and its competitors.
Is Diagnosticos da America's Total Liabilities too high?
Diagnosticos da America's current Total Liabilities is R$10,918 Mil. Overall, Diagnosticos da America has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diagnosticos da America's Total Liabilities compare to TMO and DHR?
Diagnosticos da America's Total Liabilities of R$10,918 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Diagnosticos da America and its competitors. Diagnosticos da America's current Total Liabilities is R$10,918 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnosticos da America stock overvalued right now?
Based on GuruFocus' analysis, Diagnosticos da America (BSP:DASA3) is currently considered Significantly Overvalued. The stock's GF Value™ is R$1.70, compared to a current price of R$2.62 — trading 54.1% above its estimated fair value. The current Total Liabilities is R$10,918 Mil. Diagnosticos da America's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Diagnosticos da America (BSP:DASA3), the current Total Liabilities is R$10,918 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnosticos da America (BSP:DASA3) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnosticos da America stock appears to be overvalued.
The current stock price of R$2.62 is trading 54.1% above its estimated GF Value™ of R$1.70.
GuruFocus considers Diagnosticos da America to be Significantly Overvalued.
Key valuation signals for BSP:DASA3:
Total Liabilities: R$10,918 Mil
GF Value™: R$1.70 vs. price of R$2.62 (54.1% above fair value)
No single metric tells the full story. See the BSP:DASA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
53GF Score
Get the complete analysis for BSP:DASA3
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:DASA3 has been successfully added to your 
